Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
04/2012
04/04/2012EP2436409A1 Container with constrained quality maintenance agent
04/04/2012EP2435048A1 Radiolabeled pde10 inhibitors
04/04/2012EP0831941B1 Iodinated neuroprobes for mapping monoamine reuptake sites
04/04/2012CN101732736B 制备锝-99m标记的DTPA-LSA的药盒及制备方法和应用 PCS and preparation method and application preparation of technetium -99m labeled DTPA-LSA's
04/03/2012US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/03/2012US8147806 Cellular labeling for nuclear magnetic resonance techniques
04/03/2012US8147805 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
04/03/2012US8147800 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
04/03/2012US8147799 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
04/03/2012US8147798 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
04/03/2012US8147730 Synthesis of small particles
03/2012
03/29/2012WO2012039908A2 Method and compound for treatment of cancer using phosphorous-32 labeled dna
03/29/2012WO2012038532A1 In vivo imaging method of mood disorders
03/29/2012WO2012037648A1 Process for chelating copper ions using cb-te2a bifunctional chelate
03/29/2012WO2012006038A3 Agents and compounds for imaging and other applications, and methods of use and synthesis thereof
03/29/2012WO2011143128A3 Multi-phasic nanostructures for imaging and therapy
03/29/2012WO2011140517A9 Methods for treating diseases of the lung
03/29/2012US20120076728 Human protein scaffold with controlled serum pharmacokinetics
03/29/2012US20120076727 In Vivo Copper-Free Click Chemistry for Delivery of Therapeutic and/or Diagnostic Agents
03/29/2012US20120076726 Protofibril selective antibodies and the use thereof
03/29/2012US20120076725 Lung cancer markers, and uses thereof
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012US20120076723 Devices and methods for the treatment of cancer
03/29/2012US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
03/28/2012EP1859041B1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
03/28/2012CN102395380A Pretargeting kit, method and agents used therein
03/28/2012CN102391318A Fluorine-18 fluorodeoxyglucose (18F-FDG) kit and application thereof in synthesis of positron emission tomography (PET) developer FDG
03/28/2012CN102391168A Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
03/27/2012US8143317 Use of xenon for treating neurointoxications
03/27/2012US8143272 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/27/2012US8143210 Enzyme treatment of foodstuffs for celiac sprue
03/27/2012US8142759 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof
03/27/2012US8142758 Alpha-emitting hydroxyapatite particles
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/22/2012US20120071728 Method for determining the gastric emptying
03/22/2012US20120071704 Mitochondrial localization of muc1
03/22/2012US20120070374 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides
03/22/2012US20120070373 Method and compound for treatment of cancer using phosphorous-32 labeled dna
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012US20120070371 Low-Density Magnesium-Aluminum-Silicate (MAS) Microparticles for Radiotherapy and/or Radioimaging
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012US20120070368 Methods of Using C-Met Modulators
03/22/2012DE102010037964B3 68Ga-Generator 68Ga generator
03/21/2012EP2431385A2 Combination therapy with chlorotoxin
03/21/2012EP2429593A2 Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function
03/21/2012EP2429592A2 Imaging tumor perfusion and oxidative metabolism using dynamic ace pet in patients with head and neck cancer during radiotherapy
03/21/2012EP2429591A1 Fluorescent phospholipid ether compounds, compositions, and methods of use
03/21/2012CN1836639B Method and apparatus for therapeutic emr treatment of the skin
03/21/2012CN102380112A Preparation method for diatrizoic-acid-modified dendrimer gold nanoparticles
03/21/2012CN102380111A Method for preparing <125>I mark product for ferroferric oxide nanoparticles and application thereof
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN101628121B Method for marking nano-hydroapatite particles by radioactive nuclide 125I
03/21/2012CN101516407B Improvement of arginase levels/activity
03/20/2012US8137932 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
03/20/2012US8137656 Method and apparatus for synthesis of [11C]phosgene using concentrated [11C] carbon monoxide with UV light
03/20/2012CA2524441C Treatment of lupus targeting the macrophages or the folate receptor
03/20/2012CA2435683C Hybridoma cell line g250 and its use for producing monoclonal antibodies
03/20/2012CA2405469C Integrin binding peptide derivatives
03/15/2012WO2012032043A1 212 pb imaging
03/15/2012WO2012032029A1 Method for rapid preparation of suitable [18f]fluoride for nucleophilic [18f]fluorination.
03/15/2012WO2012031457A1 A medicine delayed release vascular embolization gel used for treating tumor and preparation process thereof
03/15/2012US20120065365 Stable Radiopharmaceutical Compositions and Methods for Their Preparation
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120064005 Radiolabeled pde10 inhibitors
03/15/2012US20120064004 Isotopologues of thalidomide
03/15/2012US20120064003 COMPLEX FOLATE-NOTA-Ga68
03/15/2012US20120064002 Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents
03/15/2012US20120064001 Anti-VEGF Antibody Compositions and Methods
03/15/2012US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063995 Non-ad5 adenoviral vectors and methods and uses related thereto
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2810952A1 Method for rapid preparation of suitable [18f]fluoride for nucleophilic [18f]fluorination
03/14/2012EP2428231A2 Biomolecule complexes as contrast agents in Positron Emission Tomography (PET) based methods for the assessment of organ function
03/14/2012EP2427218A2 Pet radiotracers for imaging fatty acid metablolism and storage
03/14/2012EP2128140B1 Method for producing 2-nitroimidazole derivative
03/14/2012EP2029178B1 Radiopharmaceutical products
03/14/2012CN102378766A Compounds compositions and methods of treating cancer and fibrotic diseases
03/14/2012CN102370997A Application of dual isotope-single photon emission computed tomography in tracing of systemic distribution and intramyocardial positioning of stem cells
03/14/2012CN102370623A Liquid-state lipid micro-particles used for delivering cerebric medicine through olfactory pathway, preparation method thereof, and preparation thereof
03/13/2012US8133983 Agonistic binding molecules to the human OX40 receptor
03/13/2012US8133473 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/13/2012US8133472 Cyclopeptides containing RGD mimetics as imaging markers for integrins
03/13/2012US8133471 CLK-peptide and SLK-peptide
03/13/2012CA2502358C Methods for purifying radiolabelled compounds
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/08/2012WO2012000841A3 11c-labelled peptide for detecting an antibody
03/08/2012WO2012000781A3 11c-labelled peptide for detecting a tumour which expresses a somatostatin receptor
03/08/2012US20120059244 Skin marker
03/08/2012US20120058049 Cromolyn derivatives and related methods of imaging and treatment
03/08/2012US20120058048 Directed radiotherapy
03/08/2012US20120058047 Method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
03/07/2012EP2426107A1 Transition metal conjugated radiopharmaceuticals useful as therapeutic and/or diagnostic agents
03/07/2012EP2425861A1 Radioactively labeled substance
03/07/2012EP2424573A2 Labeled molecular imaging agents, methods of making and methods of use
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 243